Vifor Pharma (Switzerland)

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Stefan D. Anker, Josep Comín Colet, Gerasimos Filippatos et al. · New England Journal of Medicine · 2009 · 2K citations · Full text

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

Piotr Ponikowski, Dirk J. van Veldhuisen, Josep Comín‐Colet et al. · European Heart Journal · 2014 · 1.2K citations · Full text

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 723 citations · Full text

Heart Failure, Iron Metabolism, Clinical Nutrition +5

Nanomedicines: addressing the scientific and regulatory gap

Sally S. Tinkle, Scott E. McNeil, Stefan Mühlebach et al. · Annals of the New York Academy of Sciences · 2014 · 500 citations · Full text

Nanoparticles, Engineering, Nanomaterials Regulations +19

Azole Fungicides: Occurrence and Fate in Wastewater and Surface Waters

Maren Kahle, Ignaz J. Buerge, Andrea Hauser et al. · Environmental Science & Technology · 2008 · 435 citations